These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29805573)

  • 21. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
    Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T
    Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequencies of PD-1- and PD-L1- positive T CD3
    Nowicka D; Grywalska E; Surdacka A; Grafka A; Roliński J
    Microb Pathog; 2019 Jan; 126():85-91. PubMed ID: 30342909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of changes in the percentage of B (CD19) and T (CD3) lymphocytes, subsets CD4, CD8 and their memory (CD45RO), and naive (CD45RA) T cells in children with immune and non-immune thyroid diseases.
    Bossowski A; Urban M; Stasiak-Barmuta A
    J Pediatr Endocrinol Metab; 2003 Jan; 16(1):63-70. PubMed ID: 12585342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer.
    Bixby DL; Yannelli JR
    Int J Cancer; 1998 Dec; 78(6):685-94. PubMed ID: 9833760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes.
    Norris S; Collins C; Doherty DG; Smith F; McEntee G; Traynor O; Nolan N; Hegarty J; O'Farrelly C
    J Hepatol; 1998 Jan; 28(1):84-90. PubMed ID: 9537869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD3+ CD4+ and CD3+ CD8+ lymphocyte subgroups and their surface receptors NKG2D and NKG2A in patients with non-small cell lung cancer.
    Yu DP; Han Y; Zhao QY; Liu ZD
    Asian Pac J Cancer Prev; 2014; 15(6):2685-8. PubMed ID: 24761885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
    Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
    Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8
    Farhood B; Najafi M; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8509-8521. PubMed ID: 30520029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
    Chi PD; Li L; Fan YY; Wu CY
    Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral lymphocytes and intracellular cytokines in C282Y homozygous hemochromatosis patients.
    Fabio G; Zarantonello M; Mocellin C; Bonara P; Corengia C; Fargion S; Fiorelli G
    J Hepatol; 2002 Dec; 37(6):753-61. PubMed ID: 12445415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.
    Vilariño N; Bruna J; Bosch-Barrera J; Valiente M; Nadal E
    Cancer Treat Rev; 2020 Sep; 89():102067. PubMed ID: 32682248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical value of Pro-GRP and T lymphocyte subpopulation for the assessment of immune functions of lung cancer patients after DC-CIK biological therapy.
    He L; Wang J; Chang D; Lv D; Li H; Zhang H
    Exp Ther Med; 2018 Feb; 15(2):1580-1585. PubMed ID: 29399130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.
    Usó M; Jantus-Lewintre E; Bremnes RM; Calabuig S; Blasco A; Pastor E; Borreda I; Molina-Pinelo S; Paz-Ares L; Guijarro R; Martorell M; Forteza J; Camps C; Sirera R
    Oncotarget; 2016 Aug; 7(33):52849-52861. PubMed ID: 27463005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells.
    Müller P; Rothschild SI; Arnold W; Hirschmann P; Horvath L; Bubendorf L; Savic S; Zippelius A
    Cancer Immunol Immunother; 2016 Jan; 65(1):1-11. PubMed ID: 26541588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenotype analysis of tumour-infiltrating lymphocytes and lymphocytes in peripheral blood in patients with renal carcinoma.
    Kopecký O; Lukesová S; Vroblová V; Vokurková D; Morávek P; Safránek H; Hlávková D; Soucek P
    Acta Medica (Hradec Kralove); 2007; 50(3):207-12. PubMed ID: 18254275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of irinotecan on the phenotype of peripheral blood leukocyte populations in patients with metastatic colorectal cancer.
    Melichar B; Touskova M; Vesely P
    Hepatogastroenterology; 2002; 49(46):967-70. PubMed ID: 12143255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
    Yoshizawa H; Chang AE; Shu SY
    Cancer Res; 1992 Mar; 52(5):1129-36. PubMed ID: 1531321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.